These stocks have jumped in the double- and triple-digits.

Morgan Stanley says U.S. equity-market leadership is beginning to expand beyond the semiconductor and AI infrastructure ...

Morgan Stanley said the recent weakness in U.S. semiconductor stocks is a sign that the market gains are broadening, with ...

Customs Department has initiated probe against its general manager, sales and marketing officer Sreekant Sreedharan of ...

This profitable Netherlands-based biotech name has produced triple-digit quarterly earnings growth.

The payment gives Aligos non-dilutive funding as it advances its pipeline of treatments for liver and viral diseases.

Morgan Stanley’s pivot is from “chip winners” to hyperscalers with AI infrastructure optionality. MSFT has the strongest mix ...

China and Hong Kong stocks rose on Monday as signs emerged that investor enthusiasm for artificial intelligence was ...

The deal values Crinetics at $85 per share in cash, representing a potential upside of about 100% from the stock’s closing ...

Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant ...

One company leads in gene-editing approvals, while the other targets surging demand in metabolic treatments. Here’s how their financials and risk profiles compare.

Brandon Capital will receive more than $300 million from the sale of Myricx, which is developing cancer-killing “biological ...